myelofibrosis
Showing NaN - NaN of 13
Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))
Recruiting
- Myelofibrosis
- Imetelstat
- Best Available Therapy (BAT)
-
La Jolla, California
- +165 more
Aug 19, 2022
Myelofibrosis Trial in Italy (A: Fludarabine + Busulphan, B: Fludarabine + Thiotepa)
Completed
- Myelofibrosis
- A: Fludarabine + Busulphan
- B: Fludarabine + Thiotepa
-
Alessandria, Italy
- +20 more
Aug 19, 2021
Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)
Completed
- Polycythemia Vera
- +2 more
- JAK2V617F mutation
-
Olomouc, Czechia
- +29 more
Dec 5, 2019
Myelofibrosis Trial in Worldwide (Ruxolitinib, Best Available Therapy (BAT))
Completed
- Myelofibrosis
- Ruxolitinib
- Best Available Therapy (BAT)
-
Innsbruck, Austria
- +60 more
Jul 11, 2019
Acute Myeloblastic Leukemia, Lymphoblastic Leukemia, Myelodysplasia Trial in Italy (Alentuzumab, Globulina antilinfocitaria)
Completed
- Acute Myeloblastic Leukemia
- +5 more
- Alentuzumab
- Globulina antilinfocitaria
-
Alessandria, Italy
- +21 more
Mar 20, 2014